HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cu2+ Embedded Three-Dimensional Covalent Organic Framework for Multiple ROS-Based Cancer Immunotherapy.

Abstract
Reactive oxygen species (ROS)-based cancer treatments have attracted much attention in recent years. However, most patients respond poorly to the monotypic ROS during these treatments. In this work, a multiple ROS-based cancer immunotherapy synergistic strategy has been developed to enhance the therapeutic effect of cancer. We prepare a three-dimensional covalent organic framework (3D COF-TATB), and embed copper ions (Cu2+) into the skeleton to obtain multifunctional nanomaterial, 3D Cu@COF-TATB. In this system, porphyrins in 3D COF-TATB serve not only as the photosensitizer for photodynamic process to produce singlet oxygen(1O2), but also as the binding sites to complex with Cu2+. Cu2+ can be reduced by the GSH to generate Cu+ to produce hydroxyl radical (•OH) through the Fenton-like reaction. Moreover, the generated multiple types of ROS induce the immunogenic cell death (ICD) of cancer cells to improve the immunogenicity and further activate an immune response for attacking the tumor. Combining with the immunoblocking inhibitor (aPD-1), 3D Cu@COF-TATB can effectively inhibit the tumor growth. This work will provide a guidance for multimodal cancer therapy in future clinical treatment settings.
AuthorsXia Zhang, Shenglin Wang, Kun Tang, Wei Pan, Huanjun Xu, Yanhua Li, Yanan Gao, Na Li, Bo Tang
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 14 Issue 27 Pg. 30618-30625 (Jul 13 2022) ISSN: 1944-8252 [Electronic] United States
PMID35763788 (Publication Type: Journal Article)
Chemical References
  • Metal-Organic Frameworks
  • Photosensitizing Agents
  • Reactive Oxygen Species
  • Copper
Topics
  • Cell Line, Tumor
  • Copper (chemistry)
  • Humans
  • Immunotherapy
  • Metal-Organic Frameworks (chemistry)
  • Neoplasms (drug therapy)
  • Photosensitizing Agents (chemistry)
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: